Application of wogonin for preparing medicine to treat or prevent hepatitis B
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- CHINA PHARM UNIV
- Publication Date
- 2006-06-14
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the field of pharmacy and relates to the application of wogonin in the preparation of medicines for treating or preventing hepatitis B. Background technique
[0002] Viral hepatitis B (hepatitis B) is an infectious disease caused by hepatitis B virus (HBV), which is mainly caused by liver inflammatory lesions and can cause multiple organ damage. , mainly affects children and young adults, and a small number of patients can be transformed into liver cirrhosis or liver cancer. Hepatitis B has become a worldwide disease that seriously threatens human health. It is also the most widespread and most harmful infectious disease in China. According to reports, about 120 million people in my country are carrying hepatitis B virus, of which more than 30 million are chronic hepatitis B patients. 350,000 people die from chronic hepatitis B-related diseases every year. Research and development of drugs for the treatment and prevention of h...